User profiles for "author:George Pentheroudakis"
George PentheroudakisDepartment of Medical Oncology, University of Ioannina Verified email at uoi.gr Cited by 21738 |
Cancer of unknown primary site
N Pavlidis, G Pentheroudakis - The Lancet, 2012 - thelancet.com
Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for
3–5% of all malignant epithelial tumours. CUP is clinically characterised as an aggressive …
3–5% of all malignant epithelial tumours. CUP is clinically characterised as an aggressive …
Cancer and pregnancy: poena magna, not anymore
G Pentheroudakis, N Pavlidis - European Journal of Cancer, 2006 - Elsevier
Cancer diagnosed during pregnancy constitutes a difficult clinical condition with a
devastating impact on the patient's somatic and psychosocial health and possibly on foetal …
devastating impact on the patient's somatic and psychosocial health and possibly on foetal …
Switching benchmarks in cancer of unknown primary: from autopsy to microarray
G Pentheroudakis, V Golfinopoulos… - European journal of cancer, 2007 - Elsevier
INTRODUCTION: Cancer of unknown primary (CUP) is associated with unknown biology
and dismal prognosis. Information on the primary site of origin is scant and has never been …
and dismal prognosis. Information on the primary site of origin is scant and has never been …
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
FA Peccatori, HA Azim, R Orecchia… - Annals of …, 2013 - annalsofoncology.org
Over the past four decades, there has been a rising trend of delaying childbearing [1]. Given
that cancer incidence increases with age, more women are either diagnosed with cancer …
that cancer incidence increases with age, more women are either diagnosed with cancer …
[HTML][HTML] ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Circulating tumour DNA (ctDNA) assays conducted on plasma are rapidly developing a
strong evidence base for use in patients with cancer. The European Society for Medical …
strong evidence base for use in patients with cancer. The European Society for Medical …
[HTML][HTML] Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K Fizazi, FA Greco, N Pavlidis, G Daugaard… - Annals of …, 2015 - annalsofoncology.org
Cancers of unknown primary site (CUPs) represent a heterogeneous group of metastatic
tumours for which a standardised diagnostic work-up fails to identify the site of origin at the …
tumours for which a standardised diagnostic work-up fails to identify the site of origin at the …
[HTML][HTML] Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
We established an international consortium to review and discuss relevant clinical evidence
in order to develop expert consensus statements related to cancer management during the …
in order to develop expert consensus statements related to cancer management during the …
Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies
HA Azim Jr, L Santoro, W Russell-Edu… - Cancer treatment …, 2012 - Elsevier
BACKGROUND: Pregnancy-associated breast cancer (PABC) is relatively rare with
considerable controversy regarding its prognosis. PATIENTS & METHODS: Two of the …
considerable controversy regarding its prognosis. PATIENTS & METHODS: Two of the …
[HTML][HTML] Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management
S Boussios, G Pentheroudakis, K Katsanos… - Annals of …, 2012 - ncbi.nlm.nih.gov
The toxicity of cancer chemotherapy is among the most important factors limiting its use.
Clear delineation and communication of benefits and risks is an essential component of …
Clear delineation and communication of benefits and risks is an essential component of …
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
S Boussios, E Seraj, G Zarkavelis, D Petrakis… - Critical reviews in …, 2016 - Elsevier
Background Cervical cancer is the fourth most common cancer affecting women worldwide.
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …